Literature DB >> 7793504

Prognostic factors in paranasal sinus cancer.

I Alvarez1, C Suárez, J P Rodrigo, F Nuñez, M J Caminero.   

Abstract

PURPOSE: This study was designed to evaluate the influence of several different prognostic factors in determining both local recurrence rates and survival in patients treated for carcinoma of the paranasal sinuses.
MATERIALS AND METHODS: A retrospective study of patients treated between January, 1975 and December, 1991 was undertaken. Hospital charts were reviewed collecting demographic, clinical, and radiographic findings, which were correlated with treatment and subsequent follow-up.
RESULTS: Carcinoma of the paranasal sinuses was identified in 129 patients. This included 95 men and 34 women with an average of 59 years. The ethmoid sinus was primarily involved in 50 patients, the maxillary sinus and 49, the nasal sinus and 25, sphenoid sinus in three in the frontal sinus and two patients. Advanced stage (T3/T4) was diagnosed in 60% of patients at presentation. The most commonly encountered histologies were squamous-cell carcinoma and adenocarcinoma. The most accurate predictors of poor prognosis were advanced T stage and involvement of the anterior skill base. Involvement of the posterior wall of the maxillary sinus, infratemporal fossa, and erosion of the orbital wall was not associated with the worst prognosis.
CONCLUSION: In spite of advances in imaging technique and surgical therapy, the primary cause of death is inability to control local disease. Diagnosis at an earlier stage is associated with improved outcome.

Entities:  

Mesh:

Year:  1995        PMID: 7793504     DOI: 10.1016/0196-0709(95)90041-1

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  9 in total

1.  [Current imaging of nasal sinuses].

Authors:  W Reith
Journal:  Radiologe       Date:  2005-09       Impact factor: 0.635

2.  Primary sphenoid sinus neoplasms: a report of four cases with common clinical presentation treated with transsphenoidal surgery and adjuvant therapies.

Authors:  Felice Esposito; Daniel F Kelly; Harry V Vinters; Antonio A F DeSalles; Joel Sercarz; Alessandra A Gorgulhos
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

3.  A Potential Link Between Prolonged Cork Exposure and Intestinal-Type Sinonasal Adenocarcinoma - Special Findings of a Retrospective Cohort Analysis.

Authors:  Diogo Alpuim Costa; Ana Monteiro; Teresa André; Susana Esteves; Isabel Sargento; Margarida Ferreira; Teresa Alexandre; Ana Clara; João Freire; António Moreira
Journal:  Front Oncol       Date:  2020-09-18       Impact factor: 6.244

Review 4.  Genetic and clinical aspects of wood dust related intestinal-type sinonasal adenocarcinoma: a review.

Authors:  José Luis Llorente; Jhudit Pérez-Escuredo; César Alvarez-Marcos; Carlos Suárez; Mario Hermsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-17       Impact factor: 2.503

Review 5.  Paranasal sinus cancer: caveats and controversies.

Authors:  John Waldron; Ian Witterick
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

Review 6.  Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis.

Authors:  Bijan Khademi; Azadeh Moradi; Sara Hoseini; Mohammad Mohammadianpanah
Journal:  Oral Maxillofac Surg       Date:  2009-12

7.  Benign lesions in mucosa adjacent to intestinal-type sinonasal adenocarcinoma.

Authors:  Blanca Vivanco; José Luis Llorente; Jhudit Perez-Escuredo; César Alvarez Marcos; Manuel Florentino Fresno; Mario A Hermsen
Journal:  Patholog Res Int       Date:  2011-04-20

8.  Impact of tumour volume on prediction of progression-free survival in sinonasal cancer.

Authors:  Florian Hennersdorf; Paul-Stefan Mauz; Patrick Adam; Stefan Welz; Anne Sievert; Ulrike Ernemann; Sotirios Bisdas
Journal:  Radiol Oncol       Date:  2015-08-21       Impact factor: 2.991

9.  Treatment of malignant tumors of the skull base with multi-session radiosurgery.

Authors:  Nicholas D Coppa; Daniel M S Raper; Ying Zhang; Brian T Collins; K William Harter; Gregory J Gagnon; Sean P Collins; Walter C Jean
Journal:  J Hematol Oncol       Date:  2009-04-02       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.